Sutro Biopharma (STRO)
US$ 0.9026-30.57%
Price Chart
Key Statistics
Market Cap
$ 68.41M
P/E Ratio
0.00
Revenue (TTM)
$ 66.43M
Volume
5.61M
52W High
$ 5.17
52W Low
$ 0.52
Dividend Yield
0.00%
Beta
1.64
Technicals
50-Day MA
0.8232
200-Day MA
1.636
52 Week High
5.17
52 Week Low
0.5231
About STRO
Sutro Biopharma, Inc. operates as a oncology company.
Employees
269
Headquarters
South San Francisco, CA
CEO
Ms. Jane Chung R.Ph.
Latest News
Here's Why Sutro Biopharma (NASDAQ:STRO) Must Use Its Cash Wisely - Yahoo Finance
2 weeks ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg